Federal Summit on Psychedelic Medicine 2026

The Psychedelic Medicine Coalition (PMC) is set to host its 2026 Federal Summit on Psychedelic Medicine in Washington, DC, on 14 May 2026. This policy-focused event gathers leaders from government, science, and advocacy to discuss the federal landscape for psychedelic-assisted therapies. Building on previous summits, the conference aims to bridge the gap between clinical research and legislative action, ensuring that policy remains informed by the latest scientific evidence.

The summit provides a forum for discussing the implementation of federal frameworks, funding for research, and the potential for psychedelic medicines to address public health crises, particularly in veterans' health and mental health services. Participants will engage in high-level discussions regarding regulatory pathways, health equity, and the integration of these treatments into national healthcare systems. The event is structured to encourage dialogue between researchers and the lawmakers responsible for the future of drug policy.

By hosting the event in the United States capital, the PMC emphasises the importance of bipartisan collaboration in the development of responsible psychedelic policy. The Summit highlights the key stakeholders involved in the legislative process and offers a curated environment for understanding the complexities of federal oversight. It serves as a vital meeting point for those committed to advancing the therapeutic potential of psychedelics through systemic reform and scientific integrity.